Your browser doesn't support javascript.
loading
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review.
Jacobsen, Laura M; Sherr, Jennifer L; Considine, Elizabeth; Chen, Angela; Peeling, Sarah M; Hulsmans, Margo; Charleer, Sara; Urazbayeva, Marzhan; Tosur, Mustafa; Alamarie, Selma; Redondo, Maria J; Hood, Korey K; Gottlieb, Peter A; Gillard, Pieter; Wong, Jessie J; Hirsch, Irl B; Pratley, Richard E; Laffel, Lori M; Mathieu, Chantal.
Afiliação
  • Jacobsen LM; University of Florida, Gainesville, FL, USA.
  • Sherr JL; Yale School of Medicine, New Haven, CT, USA.
  • Considine E; Yale School of Medicine, New Haven, CT, USA.
  • Chen A; University of Florida, Gainesville, FL, USA.
  • Peeling SM; University of Florida, Gainesville, FL, USA.
  • Hulsmans M; University Hospital Leuven, Leuven, Belgium.
  • Charleer S; University Hospital Leuven, Leuven, Belgium.
  • Urazbayeva M; Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Tosur M; Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Alamarie S; Children's Nutrition Research Center, USDA/ARS, Houston, TX, USA.
  • Redondo MJ; Stanford University School of Medicine, Stanford, CA, USA.
  • Hood KK; Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Gottlieb PA; Stanford University School of Medicine, Stanford, CA, USA.
  • Gillard P; Barbara Davis Center, University of Colorado School of Medicine, Aurora, CO, USA.
  • Wong JJ; University Hospital Leuven, Leuven, Belgium.
  • Hirsch IB; Children's Nutrition Research Center, USDA/ARS, Houston, TX, USA.
  • Pratley RE; University of Washington School of Medicine, Seattle, WA, USA.
  • Laffel LM; AdventHealth Translational Research Institute, Orlando, FL, USA.
  • Mathieu C; Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.
Commun Med (Lond) ; 3(1): 132, 2023 Oct 05.
Article em En | MEDLINE | ID: mdl-37794113
In the last decade, there have been significant advances in how technology is used in the treatment of people living with type 1 diabetes. These technologies primarily aim to help manage blood sugar levels. Here, we reviewed research published over the last decade to evaluate the impact of such technologies on type 1 diabetes treatment. We find that various types of novel technologies, such as devices to monitor blood sugar levels continuously or deliver insulin, improve important diabetes-related measures and can reduce the risk of having low blood sugar levels. Importantly, several studies showed a positive impact of technologies on quality of life in people living with diabetes. Our findings highlight the benefits of novel technologies in the treatment of type 1 diabetes and identify areas for further research to optimize and personalize diabetes care.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Commun Med (Lond) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Aspecto: Patient_preference Idioma: En Revista: Commun Med (Lond) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido